// App-Quantinova.ai

OC 17.5 : Direct Oral Anti-Coagulant (DOAC) external quality assessment (EQA) scheme assay results and interpretations from UKNEQAS BC DOAC Survey 19 2021.

Researchers

Presenter

  • C. Reilly-Stitt

Principal Investigators

  • A. Lowe

  • I. Jennings

  • S. Kitchen

  • D. Kitchen

  • I. Walker

Medical Centers

  • UK NEQAS Blood Coagulation, SHEFFIELD, England, United Kingdom

  • UK NEQAS BC, Sheffield, England, United Kingdom

  • Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom

  • NEQAS Blood Coagulation, Sheffield, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A